Wyszukiwarka
Abstrakt
Background Ketamine is currently gaining attention as a rapid-acting antidepressant for treatment-resistant depression (TRD). However, many patients fail to respond, and limited data exist on predictors of non-response. This study aims to characterize the sociodemographic and clinical features associated with non-response to ketamine among TRD patients. Methods This is a post-hoc analysis of a naturalistic observational study, which enrolled 40 inpatients with treatment-resistant major depressive disorder and analyzed sociodemographic and clinical features in responders and non-responders stratified per Montgomery-Åsberg Depression Rating Scale (MADRS) during short-term ketamine administration (intravenous dosage: 0,5 mg/kg and orally: 2.0 or 2.5 mg/kg) that comprise over 4 weeks. Results In this study, 30 patients (75%) were classified as non-responders. No significant differences were detected among sociodemographic and clinical features beyond the history of substance use disorder (SUD) – only 53.3% of non-responders reported prior SUD (vs. 100%; p = 0.0075) and a lower number of psychiatric comorbidities (p = 0.0381). Conclusion This study highlights key characteristics of TRD non-responders to ketamine, including lower rates of SUD and fewer psychiatric comorbidities. These findings suggest that a higher burden of traditional TRD risk factors may not limit ketamine efficacy and could even enhance response compared to “pure” major depressive disorder. Identifying potential non-responders early can optimize treatment decisions, reduce ineffective exposure, and guide future research on improving TRD management.
Cytowania
-
0
CrossRef
-
0
Web of Science
-
0
Scopus
Autorzy (6)
-
Michał Walaszek
-
Wiesław Jerzy Cubała
-
Zofia Kachlik
-
Michał Pastuszak
-
Aleksander Kwaśny
Cytuj jako
Pełna treść
pełna treść publikacji nie jest dostępna w portalu
Słowa kluczowe
Informacje szczegółowe
- Kategoria:
- Publikacja w czasopiśmie
- Typ:
- artykuły w czasopismach dostępnych w wersji elektronicznej [także online]
- Opublikowano w:
-
Pharmacological Reports
ISSN: 1734-1140 - Język:
- angielski
- Rok wydania:
- 2025
- Opis bibliograficzny:
- Walaszek M., Cubała W. J., Kachlik Z., Pastuszak M., Pastuszak K., Kwaśny A., Non-response to short-term ketamine use for treatment-resistant depression, Pharmacological Reports, 2025,10.1007/s43440-025-00730-9
- DOI:
- Cyfrowy identyfikator dokumentu elektronicznego (otwiera się w nowej karcie) 10.1007/s43440-025-00730-9
- Źródła finansowania:
-
- Po stronie autorów spoza PG
- Weryfikacja:
- Politechnika Gdańska
wyświetlono 0 razy
Publikacje, które mogą cię zainteresować
Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment
- A. Kwaśny,
- W. J. Cubała,
- A. Włodarczyk
- + 1 autorów
Differential expression profile between amygdala and blood during chronic lithium treatment in a rat model of depression – a pilot study
- K. Sakrajda,
- D. Szczepankiewicz,
- J. Nowakowska
- + 7 autorów
Underdiagnosis of Major Depressive Episodes in Hemodialysis Patients: The Need for Screening and Patient Education.
- W. Orzechowski,
- W. Buczek,
- J. E. Szczerba
- + 6 autorów